- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03521388
Internet-based Program for Prevention and Early Intervention of Adolescent Depression
Efficacy of a Stepped Internet-based Program for Prevention and Early Intervention of Depression in Adolescents
Background: Depression is prevalent and can have devastating effects on the life of adolescents. Computerized intervention programs for depression have shown positive results. There is less evidence in prevention and early treatment for depression in Latin American adolescents.
Purpose: The purpose of this study is to determine whether a stepped internet-based program is effective to prevent and early intervene depression in adolescents attending 9th to 11th grade in eight schools in Santiago, Chile.
Study design: A two-arm cluster-randomized clinical trial will be carried out with approximately 600 adolescents.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Region Metropolitana
-
Santiago, Region Metropolitana, Chile, 8380455
- CEMERA, Faculty of Medicine, Universidad de Chile
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Attending from ninth grade to eleventh grade in the eight participating schools.
- Informed consent and informed assent.
- Score in the depression questionnaire PHQ-9 adolescent version between 5 and 14.
Exclusion Criteria:
- High suicide risk defined by score in question 9 of the PHQ-9 adolescent version of 2 or more.
- Current treatment with antidepressant drugs.
- Current treatment with psychotherapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
The intervention consists of an Internet-based program. The program will last 3 months, with subsequent monthly reinforcement sessions for other 3 months. The program is stepped, so that the more depressive symptomatology the more intensive program and consists of more components. The students will interact with the program via a monitoring and feedback e-mail with 3 questions of the PHQ--9- adolescent version (1st, 2nd & 9th question) that they will receive every 2 weeks and a Website that will allow them to access to psycho-educational videos and information. There will also in the Website sections that will provide emergency information, the possibility of a contact via e-mail, and group chats. Adolescents with more depressive symptoms or suicidal risk will be invited to participate in an online counselling appointment or a face to face assessment with a mental health professional of the program. |
The adolescents will be registered in the Website www.cuidatuanimo.org
|
|
Other: Control group
The comparison group will receive general psychoeducation of depression in adolescents and will be on the waiting list to receive the intervention in the event that its efficacy is demonstrated.
|
The adolescents will visit the Website www.cuidatuanimo.org, but they can not register
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive Symptoms
Time Frame: 6 months after baseline assessment
|
Patient Health Questionnaire-9 (PHQ-9) adolescent version, total score varies between 0 and 27, higher values represent a worse outcome
|
6 months after baseline assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive Symptoms
Time Frame: 12 months after baseline assessment
|
Patient Health Questionnaire-9 (PHQ-9) adolescent version, total score varies between 0 and 27, higher values represent a worse outcome
|
12 months after baseline assessment
|
|
Anxiety Symptoms
Time Frame: 6 and 12 months after baseline assessment
|
Generalized Anxiety Disorder-7 (GAD-7) adolescent version, total score varies between 0 and 21, higher values represent a worse outcome
|
6 and 12 months after baseline assessment
|
|
Health-Related Quality of Life Index
Time Frame: 6 and 12 months after baseline assessment
|
KIDSCREEN-10 index, total score varies between -3.53 and 83.8, higher values represent a better outcome
|
6 and 12 months after baseline assessment
|
|
Social Problem Solving Skills
Time Frame: 6 and 12 months after baseline assessment
|
Social Problem Solving Inventory-Revised Short Form (SPSI-RS), positive problem subscale orientation, and rational problem solving subscale, total score of each subscale varies between 0 to 20, higher scores represent better outcome
|
6 and 12 months after baseline assessment
|
|
Dysfunctional Thoughts
Time Frame: 6 and 12 months after baseline assessment
|
Children's Automatic Thought Questionnaire (CATS), personal failure subscale, total score of the subscale varies between 0 and 40, higher values represent worse outcome
|
6 and 12 months after baseline assessment
|
|
Emotion Regulation
Time Frame: 6 and 12 months after baseline assessment
|
Emotion Regulation Questionnaire (ERQ), reappraisal subscale, total score of the subscale varies between 6 and 42, higher values represent better outcome
|
6 and 12 months after baseline assessment
|
|
Depression Stigma
Time Frame: 6 and 12 months after baseline assessment
|
Depression Stigma Scale (DSS), personal stigma subscale, total score of the subscale varies between 0 and 36, higher values represent worse outcome
|
6 and 12 months after baseline assessment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Vania Martinez, PhD, University of Chile
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FONDECYT 1161696
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.